Troost EG - Search Results

1

Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients.

Govaert SL, Troost EG, Schuurbiers OC, de Geus-Oei LF, Termeer A, Span PN, Bussink J. Govaert SL, et al. Among authors: troost eg. Radiat Oncol. 2012 Sep 7;7:150. doi: 10.1186/1748-717X-7-150. Radiat Oncol. 2012. PMID: 22958781 Free PMC article.

2

Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines.

Troost EG, Bussink J, Kaanders JH, van Eerd J, Peters JP, Rijken PF, Boerman OC, van der Kogel AJ. Troost EG, et al. Radiother Oncol. 2005 Aug;76(2):194-9. doi: 10.1016/j.radonc.2005.06.031. Radiother Oncol. 2005. PMID: 16024110

3

Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.

Troost EG, Laverman P, Kaanders JH, Philippens M, Lok J, Oyen WJ, van der Kogel AJ, Boerman OC, Bussink J. Troost EG, et al. Radiother Oncol. 2006 Aug;80(2):157-64. doi: 10.1016/j.radonc.2006.07.023. Epub 2006 Aug 14. Radiother Oncol. 2006. PMID: 16905213

4

18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.

Troost EG, Vogel WV, Merkx MA, Slootweg PJ, Marres HA, Peeters WJ, Bussink J, van der Kogel AJ, Oyen WJ, Kaanders JH. Troost EG, et al. J Nucl Med. 2007 May;48(5):726-35. doi: 10.2967/jnumed.106.037473. J Nucl Med. 2007. PMID: 17475960 Free article. Clinical Trial.

5

Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts.

Troost EG, Laverman P, Philippens ME, Lok J, van der Kogel AJ, Oyen WJ, Boerman OC, Kaanders JH, Bussink J. Troost EG, et al. Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1803-11. doi: 10.1007/s00259-008-0772-7. Epub 2008 Apr 18. Eur J Nucl Med Mol Imaging. 2008. PMID: 18421457

6

18F-FDG and 18F-FLT do not discriminate between reactive and metastatic lymph nodes in oral cancer.

Troost EG, Bussink J, Oyen WJ, Kaanders JH. Troost EG, et al. J Nucl Med. 2009 Mar;50(3):490-1. doi: 10.2967/jnumed.108.055962. Epub 2009 Feb 17. J Nucl Med. 2009. PMID: 19223420 Free article. No abstract available.

7

Innovations in radiotherapy planning of head and neck cancers: role of PET.

Troost EG, Schinagl DA, Bussink J, Boerman OC, van der Kogel AJ, Oyen WJ, Kaanders JH. Troost EG, et al. J Nucl Med. 2010 Jan;51(1):66-76. doi: 10.2967/jnumed.108.061499. Epub 2009 Dec 15. J Nucl Med. 2010. PMID: 20009000 Free article. Review.

8

Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity.

Troost EG, Bussink J, Slootweg PJ, Peeters WJ, Merkx MA, van der Kogel AJ, Oyen WJ, Kaanders JH. Troost EG, et al. J Nucl Med. 2010 May;51(5):713-9. doi: 10.2967/jnumed.109.071910. Epub 2010 Apr 15. J Nucl Med. 2010. PMID: 20395329 Free article.

9

18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors.

Troost EG, Bussink J, Hoffmann AL, Boerman OC, Oyen WJ, Kaanders JH. Troost EG, et al. J Nucl Med. 2010 Jun;51(6):866-74. doi: 10.2967/jnumed.109.069310. Epub 2010 May 19. J Nucl Med. 2010. PMID: 20484426 Free article. Clinical Trial.

10

PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.

Hoeben BA, Kaanders JH, Franssen GM, Troost EG, Rijken PF, Oosterwijk E, van Dongen GA, Oyen WJ, Boerman OC, Bussink J. Hoeben BA, et al. Among authors: troost eg. J Nucl Med. 2010 Jul;51(7):1076-83. doi: 10.2967/jnumed.109.073189. Epub 2010 Jun 16. J Nucl Med. 2010. PMID: 20554724 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters